Matches in SemOpenAlex for { <https://semopenalex.org/work/W4221021567> ?p ?o ?g. }
- W4221021567 endingPage "691" @default.
- W4221021567 startingPage "691" @default.
- W4221021567 abstract "The current study aimed to evaluate the anti-diabetic effects of canagliflozin (CANA) and indapamide (INDA) and their impacts as adiponectin modulators in experimentally induced type 2 diabetes mellitus (T2DM). T2DM was associated with a significant rise in blood glucose level and HbA1C%, andreduced adiponectin and insulin secretions. Moreover, the malondialdehyde (MDA) contents in both the epididymal adipocytes and soleus muscle significantly escalated, while the total antioxidant capacity (TAC) and epididymal adipocyte Nrf2 expression significantly declined. Moreover, serum TNF-α, epididymal adipocyte's NOD-like receptor protein 3, NLRP3, NF-κB and CD68 expressions markedly escalated, and serum IL-10 significantly declined. Furthermore, there was a significant escalation in PPARγ expression in epididymal adipocytes, with a significant reduction in soleus muscle's expression of IRS1. CANA and INDA treatments markedly reduced blood glucose levels, increased adiponectin and insulin secretion, enhanced anti-oxidant defenses, and reduced oxidative burden, with marked anti-inflammatory impact. Interestingly, the impact of indapamide on DM indices and oxidative and inflammatory changes was comparable to that of canagliflozin. Nevertheless, indapamide had a superior effect compared to canagliflozin on HbA1c%, expression of IRS1 and reduction of NF-κB and CD68 expressions. INDA could be effective in regulating T2DM, with underlined anti-diabetic, antioxidant, and anti-inflammatory properties. INDA increased IRS1 expression and modified adiponectin/NLRP3/PPARγ crosstalk. The impacts of INDA are comparable to those of the standard anti-diabetic drug CANA." @default.
- W4221021567 created "2022-04-03" @default.
- W4221021567 creator A5010490825 @default.
- W4221021567 creator A5033197027 @default.
- W4221021567 creator A5074959658 @default.
- W4221021567 creator A5087633721 @default.
- W4221021567 creator A5090843496 @default.
- W4221021567 date "2022-03-31" @default.
- W4221021567 modified "2023-10-15" @default.
- W4221021567 title "Indapamide Increases IRS1 Expression and Modifies Adiponectin/NLRP3/PPARγ Crosstalk in Type 2 Diabetic Rats" @default.
- W4221021567 cites W1080222946 @default.
- W4221021567 cites W114299895 @default.
- W4221021567 cites W1941461807 @default.
- W4221021567 cites W1943440080 @default.
- W4221021567 cites W1968041660 @default.
- W4221021567 cites W1970318048 @default.
- W4221021567 cites W1979987305 @default.
- W4221021567 cites W1981261500 @default.
- W4221021567 cites W1982933214 @default.
- W4221021567 cites W1988356342 @default.
- W4221021567 cites W1991264488 @default.
- W4221021567 cites W1995161836 @default.
- W4221021567 cites W1998482930 @default.
- W4221021567 cites W2017918734 @default.
- W4221021567 cites W2021187035 @default.
- W4221021567 cites W2048032544 @default.
- W4221021567 cites W2059582640 @default.
- W4221021567 cites W2061795030 @default.
- W4221021567 cites W2064817214 @default.
- W4221021567 cites W2068293372 @default.
- W4221021567 cites W2076310317 @default.
- W4221021567 cites W2079793058 @default.
- W4221021567 cites W2080774205 @default.
- W4221021567 cites W2097784879 @default.
- W4221021567 cites W2098270306 @default.
- W4221021567 cites W2100017297 @default.
- W4221021567 cites W2101477352 @default.
- W4221021567 cites W2111817213 @default.
- W4221021567 cites W2112929152 @default.
- W4221021567 cites W2113544353 @default.
- W4221021567 cites W2138493608 @default.
- W4221021567 cites W2145460170 @default.
- W4221021567 cites W2145792347 @default.
- W4221021567 cites W2156671657 @default.
- W4221021567 cites W2160234571 @default.
- W4221021567 cites W2171553260 @default.
- W4221021567 cites W2175219657 @default.
- W4221021567 cites W2318234937 @default.
- W4221021567 cites W2568617469 @default.
- W4221021567 cites W2601779664 @default.
- W4221021567 cites W2607031541 @default.
- W4221021567 cites W2724387076 @default.
- W4221021567 cites W2765579457 @default.
- W4221021567 cites W2790286202 @default.
- W4221021567 cites W2795222338 @default.
- W4221021567 cites W2804546729 @default.
- W4221021567 cites W2837512072 @default.
- W4221021567 cites W2884101530 @default.
- W4221021567 cites W2884776261 @default.
- W4221021567 cites W2895752892 @default.
- W4221021567 cites W2919542832 @default.
- W4221021567 cites W2951412044 @default.
- W4221021567 cites W2963543515 @default.
- W4221021567 cites W2966227990 @default.
- W4221021567 cites W2989340312 @default.
- W4221021567 cites W3001210893 @default.
- W4221021567 cites W3004939147 @default.
- W4221021567 cites W3015379732 @default.
- W4221021567 cites W3017357411 @default.
- W4221021567 cites W3025400362 @default.
- W4221021567 cites W3043840333 @default.
- W4221021567 cites W3045243189 @default.
- W4221021567 cites W3045552686 @default.
- W4221021567 cites W3083174088 @default.
- W4221021567 cites W3118601063 @default.
- W4221021567 cites W3152629678 @default.
- W4221021567 cites W3186298241 @default.
- W4221021567 cites W4292318934 @default.
- W4221021567 cites W91646717 @default.
- W4221021567 doi "https://doi.org/10.3390/antiox11040691" @default.
- W4221021567 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35453376" @default.
- W4221021567 hasPublicationYear "2022" @default.
- W4221021567 type Work @default.
- W4221021567 citedByCount "3" @default.
- W4221021567 countsByYear W42210215672022 @default.
- W4221021567 countsByYear W42210215672023 @default.
- W4221021567 crossrefType "journal-article" @default.
- W4221021567 hasAuthorship W4221021567A5010490825 @default.
- W4221021567 hasAuthorship W4221021567A5033197027 @default.
- W4221021567 hasAuthorship W4221021567A5074959658 @default.
- W4221021567 hasAuthorship W4221021567A5087633721 @default.
- W4221021567 hasAuthorship W4221021567A5090843496 @default.
- W4221021567 hasBestOaLocation W42210215671 @default.
- W4221021567 hasConcept C126322002 @default.
- W4221021567 hasConcept C134018914 @default.
- W4221021567 hasConcept C171089720 @default.
- W4221021567 hasConcept C185592680 @default.
- W4221021567 hasConcept C2776175234 @default.